Order Article Reprints
Journal: Antioxidants, 2023
Volume: 12
Number: 1363
Article:
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease
Authors:
by
James Li, Sandra Arest, Bartlomiej Olszowy, John Gordon, Carlos A. Barrero and Oscar Perez-Leal
Link:
https://www.mdpi.com/2076-3921/12/7/1363
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.